| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Institut für Medizinische Mikrobiologie und Hygiene, Universität Regensburg, Franz-Josef-Strauß-Alle 11, D-93053 Regensburg, Germany
2 Institut für Klinische Mikrobiologie und Immunologie, Frohbergstrasse 3, CH-9001, St Gallen, Switzerland
Parvovirus B19 is the causative agent of a variety of clinical manifestations, ranging from asymptomatic to severe infection. The basis for this complex pattern of B19-associated diseases is as yet poorly understood. In general there are two different possibilities: firstly, the infected individuals may have a genetic or acquired predisposition, which renders them susceptible for a certain course of infection; secondly, differences in the B19 genome may result in different outcomes of infection. In order to investigate this second possibility we have partially sequenced the genomes of 20 different B19 isolates derived from serum samples from patients with various B19-associated diseases. Four distinct regions, which cover nearly half of the genome and include parts of the coding regions of all three major B19 proteins - NS1, VP1 and VP2, were selected for sequencing. Comparisons between the different extracted virus isolates at the DNA and protein levels revealed that isolates from patients with persistent parvovirus B19 infection show a tendency towards higher genome variability with respect to isolates derived from persons with acute infection.
Received 9 February 1996;
accepted 10 April 1996.
This article has been cited by other articles:
|
|
 |
|
  B. Schneider, A. Hone, R. H. Tolba, H.-P. Fischer, J. Blumel, and A. M. Eis-Hubinger Simultaneous persistence of multiple genome variants of human parvovirus B19 J. Gen. Virol., January 1, 2008; 89(1): 164 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Toan, A. Duechting, P. G. Kremsner, L. H. Song, M. Ebinger, S. Aberle, V. Q. Binh, D. N. Duy, J. Torresi, R. Kandolf, et al. Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients. J. Gen. Virol., October 1, 2006; 87(Pt 10): 2941 - 2949. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Norja, K. Hokynar, L.-M. Aaltonen, R. Chen, A. Ranki, E. K. Partio, O. Kiviluoto, I. Davidkin, T. Leivo, A. M. Eis-Hubinger, et al. Bioportfolio: Lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue PNAS, May 9, 2006; 103(19): 7450 - 7453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Servant, S. Laperche, F. Lallemand, V. Marinho, G. De Saint Maur, J. F. Meritet, and A. Garbarg-Chenon Genetic Diversity within Human Erythroviruses: Identification of Three Genotypes J. Virol., August 12, 2002; 76(18): 9124 - 9134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Heegaard and K. E. Brown Human Parvovirus B19 Clin. Microbiol. Rev., July 1, 2002; 15(3): 485 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. V. Lukashov and J. Goudsmit Evolutionary Relationships among Parvoviruses: Virus-Host Coevolution among Autonomous Primate Parvoviruses and Links between Adeno-Associated and Avian Parvoviruses J. Virol., March 15, 2001; 75(6): 2729 - 2740. [Abstract] [Full Text]
|
|
|
|
|
|
M. Bendinelli, M. Pistello, F. Maggi, C. Fornai, G. Freer, and M. L. Vatteroni Molecular Properties, Biology, and Clinical Implications of TT Virus, a Recently Identified Widespread Infectious Agent of Humans Clin. Microbiol. Rev., January 1, 2001; 14(1): 98 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dorsch, B. Kaufmann, U. Schaible, E. Prohaska, H. Wolf, and S. Modrow The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability J. Gen. Virol., January 1, 2001; 82(1): 191 - 199. [Abstract] [Full Text]
|
|
|
|
|
|
K. Hokynar, J. Brunstein, M. Söderlund-Venermo, O. Kiviluoto, E. K. Partio, Y. Konttinen, and K. Hedman Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue J. Gen. Virol., April 1, 2000; 81(4): 1017 - 1025. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Sato, E. Matsuda, K. Kamisango, H. Iwasaki, S. Matsubara, and Y. Matsunaga Development of a Hypersensitive Detection Method for Human Parvovirus B19 DNA J. Clin. Microbiol., March 1, 2000; 38(3): 1241 - 1243. [Abstract] [Full Text]
|
|
|
|
|
|
A. Olofsson, C. Mittelholzer, L. Treiberg Berndtsson, L. Lind, T. Mejerland, and S. Belák Unusual, High Genetic Diversity of Aleutian Mink Disease Virus J. Clin. Microbiol., December 1, 1999; 37(12): 4145 - 4149. [Abstract] [Full Text]
|
|
|
|
|
|
Q. T. Nguyen, C. Sifer, V. Schneider, X. Allaume, A. Servant, F. Bernaudin, V. Auguste, and A. Garbarg-Chenon Novel Human Erythrovirus Associated with Transient Aplastic Anemia J. Clin. Microbiol., August 1, 1999; 37(8): 2483 - 2487. [Abstract] [Full Text]
|
|
|
|
|
|
A. Gigler, S. Dorsch, A. Hemauer, C. Williams, S. Kim, N. S. Young, S. Zolla-Pazner, H. Wolf, M. K. Gorny, and S. Modrow Generation of Neutralizing Human Monoclonal Antibodies against Parvovirus B19 Proteins J. Virol., March 1, 1999; 73(3): 1974 - 1979. [Abstract] [Full Text]
|
|
|
|
|
|
P Biagini, P Gallian, H Attoui, J. Cantaloube, P de Micco, and X de Lamballerie Determination and phylogenetic analysis of partial sequences from TT virus isolates J. Gen. Virol., February 1, 1999; 80(2): 419 - 424. [Abstract]
|
|
|
|
|
|
A Gray, L Guillou, J Zufferey, F Rey, A. Kurt, P Jichlinski, H. Leisinger, and J Benhattar Persistence of parvovirus B19 DNA in testis of patients with testicular germ cell tumours J. Gen. Virol., March 1, 1998; 79(3): 573 - 579. [Abstract]
|
|
|
|
|
|
R. Gareus, A. Gigler, A. Hemauer, M. Leruez-Ville, F. Morinet, H. Wolf, and S. Modrow Characterization of cis-Acting and NS1 Protein-Responsive Elements in the p6 Promoter of Parvovirus B19 J. Virol., January 1, 1998; 72(1): 609 - 616. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
